4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-18-038398
Options or other derivatives
- Director acquired 17,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| POTTER MYRTLE S Director | 2018-06-01 | Grant or award · Stock Options (right to buy) | +13,000 | 13,000 | D: show line 1 in the form | ||
| POTTER MYRTLE S Director | 2018-06-01 | Grant or award · Stock Options (right to buy) | +4,000 | 4,000 | D: show line 2 in the form |
Loading xslF345X03/a4.xml…